ABSTRACT: Introduction: It is a challenge to find participants for Alzheimer’s disease (AD) prevention trials within a short period of time. The European Prevention of Alzheimer’s Dementia Registry (EPAD) aims to facilitate recruitment by preselecting subjects from ongoing cohort studies. This article introduces this novel approach. Methods: A virtual registry, with access to risk factors…
DetailsThe first quarter of 2016 started with great intensity! We were busy working towards recruiting the very first research participant into our study and should reach this important milestone early next month. A serious engagement of the entire EPAD family was also needed for the mandatory scientific and financial progress report to the Innovative…
DetailsOn 3rd November, we presented the first analysis of the EPAD data at CTAD (Clinical Trials on Alzheimer’s Disease) in Boston, USA. This analysis was primarily illustrative as did not come from the first data wave officially to be released when we have full baseline data from our first 500 research participants (due early…
DetailsThis is a unique opportunity for a future clinical academic neuroradiologist to gain research training experience while working on the neuroimaging data in the European Prevention of Alzheimer’s Dementia, EPAD research programme. http://ep-ad.org You will be based in a world-leading Academic Neuroradiology Department (under Professor Joanna Wardlaw), partnering with the Centre for Dementia Prevention (CDP)…
DetailsOur project leader Professor Craig Ritchie (pictured) is the new Chair of the Scottish Dementia Research Consortium (SDRC). SDRC is a membership based organisation which aims to support the development and expansion of high quality, co-ordinated, collaborative dementia research throughout Scotland. On 29 November, Alzheimer Scotland published an article on its website entitled “Help shape…
DetailsThe European Prevention of Alzheimer’s Dementia (EPAD) project launched in 2017 its EPAD Academy that is aiming to efficiently leverage EPAD resources to foster and develop academic research capacity and output in Alzheimer’s disease (AD) across Europe for maximum global impact. The EPAD Academy is first focusing on activities to support early career researchers. For…
DetailsIn October 2018, two articles about the EPAD project were published. On 29 October, the journal Dementia published an article entitled “Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes”. The article led by Sarah Gregory from the University of Edinburgh (UK) described how the PREVENT Dementia panel forms…
DetailsThis year, the European Prevention of Alzheimer’s Dementia (EPAD) general assembly meeting was held in Amsterdam, under the banner “How to assure sustainability”. It was hosted by VU University Medical Center (VUmc) Amsterdam and kindly sponsored by VUmc, Amgen, Novartis and Janssen. The meeting provided a chance to gather everyone from across many different…
DetailsOn World Alzheimer’s Day, the members of the EPAD initiative have reached a new milestone where the EPAD Longitudinal Cohort Study (LCS) has screened more than 1,000 research participants. Within EPAD, the team at University Of Oxford (UOF) has been recruiting successfully and recruited the 1,000th participant. Dr Vanessa Raymont, principal investigator of the EPAD…
DetailsEPAD recruited its first French research participant in September 2016 via the Gerontopole of Toulouse University Hospital (CHUT, Toulouse, France). It was the first site to open in France and the fourth in Europe and has currently recruited over 130 participants. The main mission of this institute is to develop research and prevention through multidisciplinary…
Details
